Adore Beauty Acquires Ikou for AU$25 Million

Jun 28, 2024

Highlights:

  • Strategic Acquisition: Adore Beauty Limited acquires Ikou, a wellness and skincare brand, for AU$25 million to boost its private label business.
  • Financial Impact: Despite the acquisition, Adore shares dropped by 2.7%; Ikou reported sales of AU$8.1 million and earnings of AU$2 million this year.
  • Leadership Changes: Adore Beauty is searching for a new CEO as Tamalin Morton steps down, with company founders retaining board seats and significant ownership stakes.

Strategic Acquisition

Adore Beauty Limited (ASX: ABY) has acquired Ikou, a wellness and skincare brand, for AU$25 million. This move is part of Adore Beauty’s strategy to enhance its private label business. The purchase includes an upfront payment of AU$20 million, with an additional AU$5 million due in 18 months. Ikou, founded 17 years ago by Naomi and Paul Whitfeld in the Blue Mountains, offers organic skincare, bath and body products, home fragrances, and herbal teas.

Complementing Existing Business

Adore Beauty’s outgoing CEO, Tamalin Morton, stated that Ikou will complement and strengthen the company's existing operations. "Ikou complements and strengthens our existing business, delivering revenue growth and margin expansion, as well as supporting private label and physical store initiatives," said Morton. The acquisition is expected to boost Adore’s private label share of revenue, enhance margin profiles, and provide a physical store presence across three premium locations in New South Wales.

Financial Impact

Despite the acquisition, Adore shares fell 2.7% on Friday morning, trading at 92 cents. Ikou, which operates stores in the Blue Mountains, Sydney, and Byron Bay, as well as an online shop, reported sales of AU$8.1 million and earnings of AU$2 million this year.

Leadership Changes

Adore Beauty is currently searching for a new CEO following Morton’s decision to step down for personal reasons later this year. Morton, who joined Adore in November 2022 from Priceline Pharmacy, has been instrumental in stabilizing the business. The company's founders, Kate Morris and James Height, who stepped down from executive roles last year, remain on the board and each control 11.05% of the company. Quadrant Private Equity holds a 32.51% stake, while Woodson Capital Management has a 6.6% share.

Challenges and Future Outlook

Adore Beauty, which floated at AU$6.75 per share three years ago, has seen its market capitalization decline due to increased costs and reduced margins. Last year, the company reported a loss of AU$600,000 on revenues of AU$180.6 million. Despite these challenges, Adore is aiming for earnings margins of 2% to 4% amidst ongoing economic pressures, including higher interest rates affecting household budgets.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com